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Latar Belakang: Fibrilasi Atrium (FA) adalah salah 
satu faktor resiko stroke. Kasus AF pada kasus 
Transient Ischemic Attack (TIA) jarang ada. 
Walaupun demikian, hal ini tidak dapat diremehkan 
karena TIA dan FA meningkatkan risiko terjadinya 
stroke. Kasus: Seorang wanita 80 tahun datang 
dengan gangguan bicara dan disorientasi onset 2 jam. 
Pasien tampak bingung dengan Skala Koma Glasgow 
13 (E4V3M6), tekanan darah 150/80 mmHg dan nadi 
147 kali/menit tidak teratur. Pada pemeriksaan 
didapatkan paresis nervus VII dan XII supranuklear 
tanpa kelemahan separuh tubuh dan membaik dalam 
24 jam. Hasil elektrokardiograf Fibrilasi Atrium. 
Pasien didiagnosis TIA dengan FA dan hipertensi 
derajat 1. Diskusi: Risiko awal stroke dengan skor 
ABCD2 pada pasien yang pernah mengalami TIA 
sebelumnya, yang dihitung dengan menjumlahkan 5 
faktor berikut : usia, tekanan darah, gejala klinis TIA, 
durasi TIA dan diabetes. Skor ABCD2 pada pasien ini 
adalah 5 (resiko sedang). Simpulan: Pasien dengan 
TIA dan Fibrilasi Atrium memerlukan pendekatan 
yang kompherensif dan pertimbangan untuk 
pemeriksaan radiologi tambahan karena keduanya 
merupakan faktor risiko mayor untuk terjadinya stroke 
iskemik.
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ABSTRACT
 
Background: Atrial fibrillation (AF) is an 
independent risk factor for stroke. The role of AF in 
Transient Ischemic Attack (TIA) is less common. 
Thus, this situation cannot be underestimated because 
both TIA and AF are increasing the risk of a patient to 
get stroke. Case: 80 year old woman presented with 
two hours onset of speech disturbance and 
disorientation. Patient was somnolent with Glasgow 
Coma Scale total 13 (E4V3M6), blood pressure was 
150/80 mmHg and heart rate 147 beats/min irregular. 
There was VII supranuclear and XII supranuclear 
cranial nerve palsy without unilateral weakness which 
completely resolved under 24 hours. Her 
electrocardiogram (ECG) showed Atrial Fibrillation. 
Working diagnosis for this patient were TIA with AF 
and hypertension stage 1. Discussion: Early risk of 
stroke seems to be best predicted with ABCD2 score 
in patient experiencing TIA before, which is 
calculated by summing up points for five independent 
factors: age, blood pressure, clinical features of TIA, 
duration of TIA and diabetes. ABCD2 score of this 
patient is 5 which classified as moderate risk. 
Conclusion: Patients with TIA and AF require a 
comprehensive approach and additional an imaging 
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Background   
Atrial fibrillation (AF) is an independent risk 
factor for stroke and a significant predictor for 
mortality.1 There are modified and non-modified 
risk factors in stroke. Non-modified such as age, 
gender, race, Transient Ischemic Attack (TIA) 
history and genetic. Modified such as high blood 
pressure, AF, diabetes, smoking, dyslipidemia 
and obesity. The proportion of AF among patients 
with ischemic stroke (IS) ranging from 19% to 
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38%. The role of AF in IS is already well 
established, whereas the role of AF in TIA is less 
common. However, based on data from large 
national TIA and stroke registers in Sweden, have 
shown that the proportion of known or recently 
diagnosed AF in patients with TIA is 18.6%. 
Thus, this situation cannot be underestimated and 
need to be carefully assesed, because both TIA 
and AF are major risk factors that can increasing 
the risk of a patient to get stroke.2 Based on data 
from Riset Kesehatan Dasar (Riskesdas) 2018, 
prevalence of stroke in Indonesia is 10.9 ‰ 3 
 
Case Report 
A 80 year old woman presented to our emergency 
department with speech disturbance and 
disorientation which lasted for 2 hours. She also 
experienced palpitation. A month ago, she 
experienced the same symptoms. She had a 
medical history of hypertension and also atrial 
fibrillation. She took bisoprolol 2,5 mg, 
clopidogrel 75 mg and amlodipin 5 mg daily for a 
month. On arrival, patients look confused with 
Glasgow Coma Scale of total 13 (E4V3M6), her 
blood pressure was 150/80 mmHg and heart rate 
147 beats/min irregular. From neurological 
examination, there was VII supranuclear and XII 
cranial nerve palsy without unilateral weakness 
which then completely resolved in 24 hours. Her 
electrocardiograph showed atrial fibrillation <fig. 
1>. Other routine blood tests showed 
hyponatremia (133 mEq/L). Working diagnosis 
for this patient were TIA with AF and 
hypertension stage 1. Patient were received 
clopidogrel 75 mg, bisoprolol 2,5 mg and 
amlodipin 5 mg. In addition, she was also given 
injection of citicoline 2 x 250 mg. Patient was 
hospitalized for 4 days and discharged after 
showing improvement in medical condition. 
However 7 days after being discharged, the 
patient was readmitted, now with unilateral 
weakness, AF and tachycardia. After CT-scan we 




Figure 1 : Irregular R-R interval with heart rate 125 beats/min indicates an atrial fibrillation from 
ECG result. 
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Figure 2 : Cerebral infarction on left cortical parietoocipital lobe 
 
Discussion  
There are several prediction models that have 
been developed to predict stroke after TIA such as 
California, Oxford or ABCD. However, at 
present, early risk of stroke seems to be best 
predicted with ABCD2 because they have the best 
sensitivity among other prediction models. 
ABCD2 score is calculated by summing up points 
for five independent factors: age, blood pressure, 
clinical features of TIA, duration of TIA and 
diabetes <table 1>.  
 
Table 1. ABCD2 score 
Criteria Cut off value score 
Age ≥ 60 years old 1 
Blood 
Pressure 












≥60 minutes 2 
 10 - 59 minutes 1 
Diabetes Yes 1 
 
 
ABCD2 score divided into 3 categories (0-3 mild, 
4-5 moderate, and 6-7 high), a score ≥ 4 would 
urge doctors to initiate patient admission for initial 
treatment and observation. ABCD2 score of the 
patient is 5 which is classified as moderate risk. 
This means that the patient had a 4.1% 2-days 
stroke risk, 5.9% 7-days stroke risk and 9.8% 90-
days stroke risk.4 Nevertheless, this scoring 
doesn’t include AF as a factor, while AF already 
proven to increase the risk of ischemic stroke by 
3-5 times.5 Thus, this patient require holistic 
approach and perhaps imaging consideration 
because this symptoms already present a month 
before. This case is interesting because this patient 
already has moderate risk of stroke caused by TIA 
and she also has AF which increase the risk of 
ischemic stroke by 3-5 times alone. Both are 
major risk factors for developing ischemic stroke. 
This theory was proved in this patient because she 
readmitted a week after discharge from hospital 
with more severe condition such as unilateral 
weakness and diagnosed as ischemic stroke. 
Based on research article from Norway, Low 
ABCD2 score predicted very low risk of stroke. 
However, patients with a high score also had a low 
risk of stroke. Urgent assessment and intervention 
are likely the main reasons for this.6 European 
stroke organisation make a several 
recommendation in 2019.7 In patients with non-
valvular AF and previous ischemic stroke or TIA, 
they do not recommend antiplatelet agents, either 
as single or dual therapy for secondary prevention. 
Vitamin K Antagonists (VKA) such as warfarin is 
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recommended for secondary prevention. 
European Stroke Organisation recommended non-
vitamin K antagonist oral anticoagulants(NOAC) 
over vitamin K antagonists for secondary 
prevention of stroke. So with the high quality of 
evidence and strong recommendation, we can 
assume that NOAC is the best treatment to prevent 
TIA with AF to develop into ischemic stroke. In 
addition, this patient should be given either 
vitamin K antagonist or NOAC rather than 
antiplatelet based on the latest evidence. 
 
Conclusion  
The combination of history taking, clinical 
presentation and ECG allowed us to make the 
diagnosis of TIA with AF and hypertension stage 
I. Patients with TIA and AF require a 
comprehensive approach and additional an 
imaging consideration because both are major risk 
factors of ischemic stroke. NOAC or VKA should 
be used as treatment for patients with TIA and AF 
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